Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease
Carolina R. C. Doorenbos(University Medical Center Groningen), Martin H. de Borst(University Medical Center Groningen), Gerjan Navis(University Medical Center Groningen), Liffert Vogt(Amsterdam Neuroscience), Jacob van den Born(University Medical Center Groningen), Ido P. Kema(University Medical Center Groningen), Milton M. de Cuba(University Medical Center Groningen)
The Journal of Steroid Biochemistry and Molecular Biology
September 22, 2011
Cited by 62
Related Papers
Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2
|American Journal of Kidney Diseases|2010|599
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411
Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2014|379
Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
|Journal of the American Society of Nephrology|2008|369